Disruption of prion protein–HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival

Glioblastomas (GBMs) are resistant to current therapy protocols and identification of molecules that target these tumors is crucial. Interaction of secreted heat-shock protein 70 (Hsp70)–Hsp90-organizing protein (HOP) with cellular prion protein (PrP C ) triggers a large number of trophic effects in...

Full description

Saved in:
Bibliographic Details
Published in:Oncogene Vol. 34; no. 25; pp. 3305 - 3314
Main Authors: Lopes, M H, Santos, T G, Rodrigues, B R, Queiroz-Hazarbassanov, N, Cunha, I W, Wasilewska-Sampaio, A P, Costa-Silva, B, Marchi, F A, Bleggi-Torres, L F, Sanematsu, P I, Suzuki, S H, Oba-Shinjo, S M, Marie, S K N, Toulmin, E, Hill, A F, Martins, V R
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 18-06-2015
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glioblastomas (GBMs) are resistant to current therapy protocols and identification of molecules that target these tumors is crucial. Interaction of secreted heat-shock protein 70 (Hsp70)–Hsp90-organizing protein (HOP) with cellular prion protein (PrP C ) triggers a large number of trophic effects in the nervous system. We found that both PrP C and HOP are highly expressed in human GBM samples relative to non-tumoral tissue or astrocytoma grades I–III. High levels of PrP C and HOP were associated with greater GBM proliferation and lower patient survival. HOP–PrP C binding increased GBM proliferation in vitro via phosphatidylinositide 3-kinase and extracellular-signal-regulated kinase pathways, and a HOP peptide mimicking the PrP C binding site (HOP 230–245 ) abrogates this effect. PrP C knockdown impaired tumor growth and increased survival of mice with tumors. In mice, intratumor delivery of HOP 230–245 peptide impaired proliferation and promoted apoptosis of GBM cells. In addition, treatment with HOP 230–245 peptide inhibited tumor growth, maintained cognitive performance and improved survival. Thus, together, the present results indicate that interfering with PrP C –HOP engagement is a promising approach for GBM therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0950-9232
1476-5594
DOI:10.1038/onc.2014.261